CIP
COLL icon

Chartwell Investment Partners’s Collegium Pharmaceutical COLL Stock Holding History

Chartwell Investment Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-38,047
Closed -$666K – 418
2020
Q2 		$666K Buy
+38,047
New +$745K 0.03% 360
2018
Q3 		– Sell
-100,704
Closed -$2.4M – 476
2018
Q2 		$2.4M Sell
100,704
-81,095
-45% -$1.99M 0.07% 336
2018
Q1 		$4.64M Sell
181,799
-2,538
-1% -$60.5K 0.16% 197
2017
Q4 		$3.4M Buy
+184,337
New +$2.64M 0.12% 263

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Chartwell Investment Partners's COLL Position: Q3 2020 in Review

Chartwell Investment Partners sold out of Collegium Pharmaceutical (COLL) in Q3 2020, closing a stake of 38,047 shares — an estimated $666K sold.

Chartwell Investment Partners first reported a position in COLL in Q4 2017 and held it in 4 quarters. The position peaked at $4.64M in Q1 2018. 140 funds tracked by Wall St. Rank hold COLL as of Q3 2020.

  • Chartwell Investment Partners reported no remaining Collegium Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Chartwell Investment Partners sold 38,047 Collegium Pharmaceutical shares in Q3 2020, an estimated $666K.
  • Chartwell Investment Partners first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 4 quarters.
  • Chartwell Investment Partners's Collegium Pharmaceutical position peaked at $4.64M in Q1 2018.
  • 140 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2020.

Based on Chartwell Investment Partners's 13F filing for Q3 2020, filed 16 Nov 2020.